| COMPLEXIN-1 Protein | |
|---|---|
| Protein Name | Complexin-1 |
| Encoded by | [CPLX1](/genes/cplx1) |
| UniProt | [O75178](https://www.uniprot.org/uniprotkb/O75178/entry) |
| Localization | Presynaptic cytosol, synaptic vesicles |
| Protein Class | Synaptic vesicle fusion regulator |
| Major Pathway | [Synaptic Transmission](/mechanisms/synaptic-transmission) |
COMPLEXIN-1 (CPLX1) is a 134-amino acid presynaptic cytosolic protein that plays a critical role in regulating synaptic vesicle fusion. It binds to assembled SNARE complexes and controls the final step of calcium-triggered synaptic vesicle fusion, acting as both a fusion clamp and a fusion facilitator[1][2]. This dual function makes complexin-1 essential for precise temporal control of neurotransmitter release.
In the nervous system, complexin-1 is expressed in most neuronal populations, with particularly high expression in cerebellar neurons, hippocampal pyramidal cells, and dopaminergic neurons. Its function is essential for normal synaptic transmission, and alterations in complexin-1 biology have been linked to disrupted neurotransmission in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis[3][4][5].
Because synaptic failure is an early and convergent event across neurodegenerative diseases, CPLX1 is relevant beyond pure synaptic physiology. The protein serves as a mechanistic marker and experimental target for understanding synaptic dysfunction in disease states.
Complexin-1 is a small protein (~15 kDa) with four functionally distinct regions[2:1][6]:
N-terminal Activating Segment (1-50 aa): This region supports efficient calcium-triggered release. It contains the "激活" (activation) function that promotes fusion when calcium enters the presynaptic terminal.
Accessory Helix (50-75 aa): This α-helix contributes to clamping of premature fusion by competing with synaptotagmin for SNARE complex binding.
Central Helix (75-110 aa): The central region contains the high-affinity SNARE-binding helix that binds to assembled SNARE bundles.
C-terminal Segment (110-134 aa): This region supports membrane association and spatial positioning at the active zone.
The domain architecture enables rapid switching between fusion states:
Clamp Function: The accessory helix competes with synaptotagmin for SNARE binding, preventing premature fusion.
Activate Function: Upon calcium influx, the N-terminal domain promotes efficient fusion completion.
SNARE Binding: The central helix binds with high affinity to assembled SNARE complexes.
At fast synapses, complexin-1 tightens temporal precision of vesicle fusion[1:1][6:1]:
Loss of complexin function generally elevates spontaneous fusion while impairing evoked synchronous release[2:2][7]:
CPLX1-dependent release control is especially relevant in:
Synaptic decline in AD includes altered levels of presynaptic proteins involved in vesicle priming and fusion[3:1][8]:
The connection between AD and complexin-1 reflects the broader concept that AD is fundamentally a synaptic failure, with early synaptic dysfunction preceding neuron loss.
In PD, presynaptic stress, dopamine-terminal degeneration, and alpha-synuclein toxicity converge on release machinery[4:1][5:1]:
The protein may be functionally impaired even when not directly mutated, reflecting the broader vulnerability of the presynaptic terminal in PD.
In ALS, cortical and spinal synaptic dysfunction precedes extensive neuronal death[5:2][9][10]:
Complexin-1 dysfunction has been implicated in:
Complexin-1 regulates SNARE complex function:
Disease states alter this regulation:
The synaptic vesicle cycle is disrupted in neurodegeneration[11]:
Complexin-1 interacts with key synaptic proteins:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| SNAP-25 | Direct binding | SNARE complex formation |
| Syntaxin-1A | Direct binding | SNARE complex formation |
| VAMP2 | Direct binding | Synaptic vesicle SNARE |
| Synaptotagmin-1 | Competitive binding | Calcium sensing |
| Munc13 | Indirect | Vesicle priming |
| Munc18 | Indirect | Syntaxin regulation |
Key milestones in complexin research:
Reim K, Wegmeyer H, Brandstatter JH, et al. Structurally and functionally unique complexins at retinal ribbon synapses. Cell. 2005. ↩︎ ↩︎
Xue M, Reim K, Chen X, et al. Distinct domains of complexin I differentially regulate neurotransmitter release. Nat Struct Mol Biol. 2007. ↩︎ ↩︎ ↩︎
Selkoe DJ. Alzheimer disease is a synaptic failure. Science. 2002. ↩︎ ↩︎
Bridi JC, Hirth F. Mechanisms of alpha-synuclein induced synaptopathy in Parkinson disease. Front Neurosci. 2018. ↩︎ ↩︎
Fogarty MJ. Driven to decay synaptic dysfunction in amyotrophic lateral sclerosis. Neural Regen Res. 2019. ↩︎ ↩︎ ↩︎
Rizo J, Rosen MK. Synaptic vesicle fusion. Annu Rev Cell Dev Biol. 2008. ↩︎ ↩︎
Kaeser-Woo YJ, Yang X, Sudhof TC. C-terminal complexin sequence is selectively required for clamping but not priming of synaptic exocytosis. Neuron. 2012. ↩︎
de Wilde MC, Overk CR, Sijben JW, et al. Meta-analysis of synaptic pathology in Alzheimer disease reveals selective molecular vulnerability. Mol Neurodegener. 2016. ↩︎
Sleigh JN, Rossor AM, Fellows AD, et al. Axonal transport and neurological disease. Nat Rev Neurol. 2014. ↩︎
Kim J, Kim D, Chung J, et al. Complexin deficiency and ALS. Acta Neuropathol Commun. 2019. ↩︎
Martin Y, Range J, Acevedo K, et al. Complexin and synaptic vesicle cycling. Elife. 2020. ↩︎